0001795091-26-000003.txt : 20260716 0001795091-26-000003.hdr.sgml : 20260716 20260715193648 ACCESSION NUMBER: 0001795091-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260716 DATE AS OF CHANGE: 20260715 EFFECTIVENESS DATE: 20260716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OS Therapies Inc CENTRAL INDEX KEY: 0001795091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 825118368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591006 FILM NUMBER: 261178401 BUSINESS ADDRESS: STREET 1: 15825 SHADY GROVE ROAD STREET 2: SUITE 135 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-297-7793 MAIL ADDRESS: STREET 1: 15825 SHADY GROVE ROAD STREET 2: SUITE 135 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: OS THERAPIES Inc DATE OF NAME CHANGE: 20191125 D 1 primary_doc.xml X0708 D LIVE 0001795091 OS Therapies Inc 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 410-297-7793 DELAWARE OS THERAPIES Inc Corporation true Paul A. Romness 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Executive Officer Director Chairman, President and Chief Executive Officer Robert G. Petit 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Executive Officer Chief Medical Officer and Chief Scientific Officer Christopher P. Acevedo 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Executive Officer Chief Financial Officer John Ciccio 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Director Avril McKean Dieser 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Director Craig Eagle 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Director Olivier Jarry 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Director Theodore F. Search 115 Pullman Crossing Road Suite 103 Grasonville MD MARYLAND 21638 Director Biotechnology Decline to Disclose 06b false 2026-06-30 false true true true false 0 9250000 1600000 7650000 false 1 0 0 0 false OS Therapies Inc /s/ Christopher P. Acevedo Christopher P. Acevedo Chief Financial Officer 2026-07-15